Provided by Tiger Fintech (Singapore) Pte. Ltd.

BOAN BIOTECH

11.420
-0.610-5.07%
Volume:5.45M
Turnover:63.82M
Market Cap:7.10B
PE:76.73
High:12.230
Open:12.060
Low:11.350
Close:12.030
52wk High:25.000
52wk Low:7.510
Shares:622.00M
HK Float Shares:622.33M
Volume Ratio:0.78
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.149
ROE:1.87%
ROA:1.33%
PB:3.21
PE(LYR):76.73
PS:8.61

Loading ...

Impact of Bulk Procurement on Commercial Logic: Can BOAN BIOTECH (06955) Recover After a 30% Stock Decline Over Two Months?

Stock News
·
Yesterday

Shandong Boan Biotechnology's (HKG:6955) Anemic Earnings Might Be Worse Than You Think

Simply Wall St.
·
Oct 07

Shandong Boan Biotechnology Reports 8.4% Rise in Revenue to RMB393.4 Million and Net Profit of RMB20.5 Million for H1 2025

Reuters
·
Sep 29

Hong Kong Stock Alert | BOAN BIOTECH (06955) Surges Over 14% with Abundant Cash Position, Institutions Optimistic About FIC Innovation Pipeline Market Potential

Stock News
·
Sep 16

Shandong Boan Biotechnology's H1 Profit Falls Despite Revenue Jump; Shares Drop 14%

MT Newswires Live
·
Aug 28

Stock Track | BOAN BIOTECH Plummets 5.22% Following 66.74% Drop in Half-Year Profit

Stock Track
·
Aug 28

BOAN BIOTECH (06955) Reports Interim Results with Shareholders' Profit of RMB 20.514 Million, Down 66.74% Year-over-Year

Stock News
·
Aug 27

Shandong Boan Biotechnology H1 Gross Profit RMB 282.6 Million

THOMSON REUTERS
·
Aug 27

Shandong Boan Biotechnology H1 Net Income RMB 20.5 Million

THOMSON REUTERS
·
Aug 27

BOAN BIOTECH (06955) Completes Placement of 48 Million Shares, Raising Net Proceeds of Approximately HK$780 Million

Stock News
·
Aug 14

Shandong Boan Biotechnology Gets China Nod for Marketing of Glycemic Control Drug

MT Newswires Live
·
Aug 08

BRIEF-Shandong Boan Biotechnology Says Dulaglutide Injection Approved For Marketing By Nmpa

Reuters
·
Aug 08

Shandong Boan Biotechnology - Dulaglutide Injection (Boyouping) Approved for Marketing in China by Nmpa

THOMSON REUTERS
·
Aug 08

BRIEF-Shandong Boan Biotechnology To Place 48 MLN Shares At HK$16.42 Per Share

Reuters
·
Aug 07

Shandong Boan Biotechnology - to Place 48 Mln Shares at HK$16.42 per Share

THOMSON REUTERS
·
Aug 07

HK Movers | HK's Biotech Shares Soar. CANbridge up 20%; Boan Biotech up 16%; Hengrui Pharma up 8%

Tiger Newspress
·
Jul 14

Shandong Boan Biotechnology Co. Ltd. Receives FDA Approval to Initiate Clinical Trials for BA1302 in the U.S

Reuters
·
Jun 17

Shandong Boan Biotechnology Raises HK$396Million from Share Placement

MT Newswires Live
·
Jun 12

Shandong Boan Biotechnology Co. Ltd. Conducted Annual General Meeting

Reuters
·
Jun 05

Shandong Boan Biotechnology Co. Ltd. Announces Placing of 38.4 Million New Shares Under General Mandate

Reuters
·
Jun 04